相关实验视频
Updated: May 27, 2025

06:38
Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
Published on: February 28, 2025
223
在体外生物可用性,生物可访问性和抗氧化能力的差异取决于氨酸4'-O-葡萄糖酸的结合类型
Young Sung Jung1, Davin Jang1, Mi-Seon Kim1
1Department of Food Science and Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea.
Food research international (Ottawa, Ont.)
|February 19, 2025
概括
葡萄糖化会影响卢托林的抗氧化作用. 素4'-O-alpha-glucoside (L4αG) 通过激活细胞通路,增强了抗氧化能力,而不仅仅是清除自由基.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 营养科学 营养科学
背景情况:
- 黄类化合物,如黄素,具有抗氧化特性.
- 糖基化可以改变黄酸的生物可用性和生物活性.
- 了解异构体特异性作用对于优化抗氧化功能至关重要.
研究的目的:
- 为了研究葡萄糖异常 (α与β) 对黄素抗氧化能力的影响.
- 为了比较体外4'-O-alpha-glucoside (L4αG) 和lutein 4'-O-beta-glucoside (L4βG) 的生物可访问性,生物可用性和生物活性.
- 阐明糖化对醇细胞内抗氧化作用的影响机制.
主要方法:
- 在体外分析生物可访问性,消化系统稳定性和甘释放.
- 使用H2O2诱导的Caco-2细胞进行细胞抗氧化活性测定.
- 研究信号通路,包括基激活蛋白激酶 (MAPK) 和核因子红色素-2-相关因子 (Nrf2).
主要成果:
- 与L4βG相比,L4αG显示出较低的水溶性,消化稳定性和糖释放率.
- 在Caco-2细胞中,L4αG显著缓解了细胞内氧化应激.
- 通过MAPK和Nrf2通路激活细胞抗氧化酶,L4αG增强了抗氧化能力.
结论:
- 在L4αG中的葡萄糖的α-解体能比L4βG更有效地增强细胞内抗氧化能力.
- L4αG的抗氧化作用主要通过激活内源抗氧化系统来调节.
- 这项研究提出了一种新的策略,用于开发基于高细胞亲和度的黄酸甘的天然抗氧化剂.
相关概念视频
Bioavailability: Overview
2.6K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.6K
Factors Influencing Bioavailability: First-Pass Elimination
6.1K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.1K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
171
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
171
Factors Affecting Drug Biotransformation: Biological
99
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
99

